4.6 Review

Genetic Clues on Implantable Cardioverter-Defibrillator Placement in Young-Age Hypertrophic Cardiomyopathy: A Case Report of Novel MYH7 Mutation and Literature Review

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

The Risk of Sudden Unexpected Cardiac Death in Children Epidemiology, Clinical Causes, and Prevention

Emanuele Monda et al.

HEART FAILURE CLINICS (2022)

Article Cardiac & Cardiovascular Systems

Hypertrophic Cardiomyopathy in RASopathies Diagnosis, Clinical Characteristics, Prognostic Implications, and Management

Michele Lioncino et al.

HEART FAILURE CLINICS (2022)

Letter Cardiac & Cardiovascular Systems

Unexplained sudden cardiac arrest in children: clinical and genetic characteristics of survivors

Emanuele Monda et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Hypertrophic Cardiomyopathy: Genetic Testing and Risk Stratification

Fergus Stafford et al.

Summary: Our understanding of the genetic basis and molecular pathogenesis of hypertrophic cardiomyopathy (HCM) is continuously evolving, with recent advances in genetic testing showing the presence of important HCM sub-groups. Genetic testing has emerged as a valuable tool for cascade genetic testing and may play a significant role in prognosis and patient management in the future. Genotype may potentially enhance risk stratification, management, treatment, and prognosis in HCM, leading to improved outcomes for patients and their families.

CURRENT CARDIOLOGY REPORTS (2021)

Article Genetics & Heredity

Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy

Augusto Akira Mori et al.

Summary: Genetic variants in sarcomeric genes are associated with the risk of sudden cardiac death and severity of left ventricular hypertrophy in hypertrophic cardiomyopathy patients. Functional variants may contribute to severe LVH, family history, and risk factors for sudden cardiac death.

FORENSIC SCIENCE INTERNATIONAL-GENETICS (2021)

Article Cardiac & Cardiovascular Systems

2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy

Steve R. Ommen et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2021)

Article Cardiac & Cardiovascular Systems

Genetic Causes of Cardiomyopathy in Children: First Results From the Pediatric Cardiomyopathy Genes Study

Stephanie M. Ware et al.

Summary: The study found that a positive family history and hypertrophic subtype of cardiomyopathy were associated with increased likelihood of genetic testing in children. Additionally, a molecular cause was identified in 21% of children who did not undergo clinical testing, highlighting the importance of genetic testing in pediatric cardiomyopathy cases.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Article Genetics & Heredity

Variants in MHY7 Gene Cause Arrhythmogenic Cardiomyopathy

Valentina Ferradini et al.

Summary: This study characterized two novel variants in the MHY7 gene that are associated with Arrhythmogenic Cardiomyopathy (ACM) in two families. The variants were found to be the molecular cause of ACM, further increasing the genetic heterogeneity of the disease. Further studies on the role of sarcomere genes in ACM pathogenesis are recommended for patients negative for desmosomal mutation screening.

GENES (2021)

Article Cardiac & Cardiovascular Systems

A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy

Anastasia Miron et al.

CIRCULATION (2020)

Article Cardiac & Cardiovascular Systems

Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy

Lazar Velicki et al.

BMC CARDIOVASCULAR DISORDERS (2020)

Review Cardiac & Cardiovascular Systems

Risk stratification in pediatric hypertrophic cardiomyopathy: Insights for bridging the evidence gap?

Stephanie J. Nakano et al.

PROGRESS IN PEDIATRIC CARDIOLOGY (2018)

Article Genetics & Heredity

Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy

J. Mathew et al.

CLINICAL GENETICS (2018)

Article Cardiac & Cardiovascular Systems

Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals

Farbod Sedaghat-Hamedani et al.

CLINICAL RESEARCH IN CARDIOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Predictors of risk for sudden death in childhood hypertrophic cardiomyopathy: the importance of the ECG risk score

Ingegerd Ostman-Smith et al.

OPEN HEART (2017)

Article Cardiac & Cardiovascular Systems

Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain

Diego Garcia-Giustiniani et al.

HEART (2015)

Article Cardiac & Cardiovascular Systems

Malignant effects of multiple rare variants in sarcomere genes on the prognosis of patients with hypertrophic cardiomyopathy

Jizheng Wang et al.

EUROPEAN JOURNAL OF HEART FAILURE (2014)

Article Cardiac & Cardiovascular Systems

Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy

Barry J. Maron et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)

Review Cardiac & Cardiovascular Systems

Hypertrophic cardiomyopathy in children

Jeffrey P. Moak et al.

HEART (2012)

Review Medicine, General & Internal

Narrative Review: Harnessing Molecular Genetics for the Diagnosis and Management of Hypertrophic Cardiomyopathy

Libin Wang et al.

ANNALS OF INTERNAL MEDICINE (2010)

Article Genetics & Heredity

Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene

R. H. Lekanne Deprez et al.

JOURNAL OF MEDICAL GENETICS (2006)

Article Cardiac & Cardiovascular Systems

A novel TPM1 mutation in a family with hypertrophic cardiomyopathy and sudden cardiac death in childhood

SL Van Driest et al.

AMERICAN JOURNAL OF CARDIOLOGY (2002)